Search research articles
Contact Us
Filters
Showing results (121-130 of 163) with videos related to
Page
of 17
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 21, 2007
Costs and quality of life of multiple sclerosis in Germany
Gisela Kobelt, Jenny Berg, Peter Lindgren, et al.
Thrombosis Research
|
March 6, 2012
Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic
Peter Salaj, Miroslav Penka, Petr Smejkal, et al.
Molecular Endocrinology (Baltimore, Md.)
|
June 2, 2005
Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells
Pradeep Reddy, Lian Liu, Chong Ren, et al.
British Journal of Sports Medicine
|
July 19, 2020
A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference group
Gunilla Journath, Niklas Hammar, Max Vikström, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 19, 2026
A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target-driven treatment regimens in oncology
Oskar Frisell, Eline Aas, Pia Sofie Henkel, et al.
Plos One
|
November 19, 2015
Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden
Gunilla Journath, Niklas Hammar, Stig Elofsson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 11, 2009
Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe--the HEALTH model
Björn Schwander, Birgit Gradl, York Zöllner, et al.
Developmental Biology
|
May 17, 2005
Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development
Pradeep Reddy, Lijun Shen, Chong Ren, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
June 26, 2023
Comparing the results from a Swedish pregnancy cohort using data from three automated placental growth factor immunoassay platforms intended for first-trimester preeclampsia prediction
Ylva Carlsson, Anna Sandström, Lina Bergman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 28, 2023
Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country Study
Gérard de Pouvourville, David Cunningham, Frank-Ulrich Fricke, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 163) with videos related to
Sort By:
Page
of 17
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 21, 2007
Costs and quality of life of multiple sclerosis in Germany
Gisela Kobelt, Jenny Berg, Peter Lindgren, et al.
Thrombosis Research
|
March 6, 2012
Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic
Peter Salaj, Miroslav Penka, Petr Smejkal, et al.
Molecular Endocrinology (Baltimore, Md.)
|
June 2, 2005
Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells
Pradeep Reddy, Lian Liu, Chong Ren, et al.
British Journal of Sports Medicine
|
July 19, 2020
A Swedish primary healthcare prevention programme focusing on promotion of physical activity and a healthy lifestyle reduced cardiovascular events and mortality: 22-year follow-up of 5761 study participants and a reference group
Gunilla Journath, Niklas Hammar, Max Vikström, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 19, 2026
A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target-driven treatment regimens in oncology
Oskar Frisell, Eline Aas, Pia Sofie Henkel, et al.
Plos One
|
November 19, 2015
Time Trends in Incidence and Mortality of Acute Myocardial Infarction, and All-Cause Mortality following a Cardiovascular Prevention Program in Sweden
Gunilla Journath, Niklas Hammar, Stig Elofsson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 11, 2009
Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe--the HEALTH model
Björn Schwander, Birgit Gradl, York Zöllner, et al.
Developmental Biology
|
May 17, 2005
Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development
Pradeep Reddy, Lijun Shen, Chong Ren, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
June 26, 2023
Comparing the results from a Swedish pregnancy cohort using data from three automated placental growth factor immunoassay platforms intended for first-trimester preeclampsia prediction
Ylva Carlsson, Anna Sandström, Lina Bergman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 28, 2023
Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country Study
Gérard de Pouvourville, David Cunningham, Frank-Ulrich Fricke, et al.
Page
of 17